Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetics of Type 2 Diabetes—Progress and Prospects

18 Sept 2020

Abstract excerpt

Type 2 diabetes mellitus (T2D) is a chronic metabolic disease resulting from insulin resistance and progressively reduced insulin secretion, which leads to impaired glucose utilization, dyslipidemia and hyperinsulinemia and progressive pancreatic beta cell dysfunction. The incidence of type 2 diabetes mellitus is increasing worldwide and nowadays T2D already became a global epidemic. The well-known...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diabetes Treatment and Management
Share to Pancreatic function and diabetes
Share to Receptor Mechanisms and Signaling

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32961860
DOI: 10.3390/ijms21186842

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics of Type 2 Diabetes—Progress and ProspectsPMID 32961860Read ↗

Pharmacogenomics and Personalized Medicine in Type 2 Diabetes Mellitus: Potential Implications for Clinical PracticeSemantic proximity Read ↗

Pharmacogenetic studies update in type 2 diabetes mellitusSemantic proximity Read ↗

Pharmacogenetics of type 2 diabetes mellitus, the route toward tailored medicineSemantic proximity Read ↗

Current progress in pharmacogenomics of Type 2 diabetes: A systemic overview.Semantic proximity Read ↗

Current Progress in Pharmacogenetics of Second-Line Antidiabetic Medications: Towards Precision Medicine for Type 2 DiabetesSemantic proximity Read ↗

Pharmacogenomics in type 2 diabetes: oral antidiabetic drugs.Semantic proximity Read ↗

Diabetes in China: Epidemiology and Genetic Risk Factors and Their Clinical Utility in Personalized Medication.Semantic proximity Read ↗

Genetics of Type 2 Diabetes: Past, Present, and Future.Semantic proximity Read ↗

Pharmacogenetics in type 2 diabetes: precision medicine or discovery tool?Semantic proximity Read ↗

Updates In Common Genetic Variants May Help Guide Drug Selection For Treating Uncontrolled DiabetesSemantic proximity Read ↗

Genetics of Type 2 Diabetes—Pitfalls and PossibilitiesSemantic proximity Read ↗

Genetics of type 2 diabetes: insights into the pathogenesis and its clinical application.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.